- ►diabetesjournals.org H Kusunoki, S Miyata, T Ohara, BF Liu, A … - Diabetes care, 2003 - Am Diabetes Assoc RESULTS—The fasting serum 3-DG level in diabetic patients was significantly (P
< 0.001) higher than that in control subjects (353 ± 110 vs. 199 ± 53 nmol/l).
The 3-DG levels were significantly (P < 0.001) elevated even in the ... Cited by 24 - Related articles - BL Direct - All 5 versions
S Tsukushi, M Kajita, S Nakamura, T Niwa - Journal of Chromatography B, 2002 - Elsevier To determine if the erythrocyte levels of 3-deoxyglucosone (3-DG) are increased
in diabetic patients, and if they correlate with glycemic status, they were
measured in diabetic patients without renal disease as well as in healthy ... Cited by 8 - Related articles - All 3 versions
Y Hasuike, T Nakanishi, Y Otaki, M Nanami, T … - American Journal of Kidney Diseases, 2002 - Elsevier From the Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo
College of Medicine, Nishinomiya, Hyogo; Division of Drug Evaluation, National
Institute of Health Sciences, Osaka; and the Department of Biochemistry, ... Cited by 12 - Related articles - BL Direct - All 12 versions
[CITATION] RAGE-dependent signaling in mononuclear phagocytes and endothelial cells generate oxidant …
H Sakiyama, M Takahashi, T Yamamoto, T … - Journal of Biochemistry, 2006 - Jpn Biochemical Soc 3-Deoxyglucosone (3-DG), a dicarbonyl compound produced by glycation, plays a
role in the modification and cross-linking of long-lived proteins. We
synthesized [ 3 H]3-DG from [ 3 H]glucose and developed an internalization ... Cited by 4 - Related articles - All 8 versions
ZH Zheng, B Anderstam, AR Qureshi, O … - Kidney international, 2002 - nature.com The effect of different experimental PD solutions on ingestive behavior was
investigated in non-uremic rats equipped with an implanted intraoral (io)
cannula through which a 1 mol/L sucrose solution was infused during tests. ... Cited by 7 - Related articles - BL Direct - All 5 versions
Y Hamada, J Nakamura, H Fujisawa, H Yago, … - Diabetes care, 1997 - Am Diabetes Assoc OBJECTIVE: To clarify the effects of glycemic control on the level of
3-deoxyglucosone (3-DG), a reactive dicarbonyl compound, in plasma from diabetic
patients. RESEARCH DESIGN AND METHODS: Fasting plasma samples were ... Cited by 15 - Related articles - BL Direct - All 7 versions
[CITATION] Epalrestat, an aldose reductase inhibitor, reduces the levels of CML protein adducts and …
A Lapolla, R Flamini, T Tonus, D Fedele, A … - Rapid Communications in Mass Spectrometry, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 18 - Related articles - BL Direct - All 3 versions
